News publication
Everything we hold that Mirage News published.
Every article we hold from Mirage News.
FeBI Technologies wins a 2.2 million dollar Australian Government grant to advance its quantum sensing blood test for iron disorders, building on an earlier Stage 1 grant, with partners including Katherine health services.
Under Mirage News ·leads this story in the feed
Six Australian quantum companies receive government grants under round two stage two of the Critical Technologies Challenge Program, supporting projects from quantum clocks to biosensors and diagnostic tools.
Also Mirage News·Dealroom·This Week in Australian Startups·Startup Daily
America's medicines regulator has approved Currus Biologics to begin human trials of CUR-001, its solid-tumour CAR T-cell therapy combination, with dosing expected from early 2027.
UQ spinout Proboxis Biotechnology has received $1.5 million via the first round of the Biointelect Venturer incubator to advance a vaccine platform against mosquito-borne diseases toward human clinical development.
ARENA is putting $8.2 million toward Electric Future's Go Electric pilot, which will trial a one-stop digital platform helping as many as 1,000 Canberra households move from gas to electric appliances.
QIMR Berghofer's Ebivanta Therapeutics wins $1.5 million plus backing from biotech incubator Biointelect Venturer's first cohort to ready its mRNA vaccine against Epstein-Barr virus for clinical testing.
Australia's competition regulator approved Peter Warren Automotive's purchase of Wakeling Automotive's new car dealerships, on condition eight local dealership sites are divested to protect competition.
An analysis of what happens to brain-implant trial participants once studies end, covering Australia's growing neurotech sector, EpiMinder's FDA approval, Synchron's funding, and recommendations from a convened panel of specialists.
Canberra is funding carbon management demonstrations: round two of a national program directs $32.6 million across seven projects, naming six recipients including Carbonaught, Australian Carbon Vault, Karbonix, MCi Carbon and Electralith.
Under RenewEconomy ·leads this story in the feed
Canberra is putting up to $26 million through ARENA behind Element Zero's Perth pilot testing whether the nation's iron ore can become low-emissions iron via a renewable-powered, molten-salt process.
The US War Department has announced an estimated US$174m equity investment, partnering with Export Finance Australia, Japan and Sojitz, to build a gallium plant at Alcoa's Wagerup refinery.
A Western Australian drone-detection project run by UXMachines with the University of Western Australia has won 190,000 dollars under the state's Defence and Research Teaming grant program.
Also Defence Connect
University of Wollongong researchers won government funding for a quantum photon-counting cancer imaging system and partnered with radiotherapy maker Elekta, moving the technology toward clinical trials.
Ashurst Perkins Coie acted for Amwins on its proposed A$8 billion consortium buyout of ASX-listed Steadfast, under which Amwins would take the underwriting agencies and KKR and Dragoneer the retail broking arm.
University of Queensland researchers, funded by an Australian grant and working with cultivated-meat firm Magic Valley, found microalgae grown on production waste can recycle nutrients and sharply cut the cost of growing meat cells.
Melbourne GRC startup CyberHeed has released Live Integrations, which continuously pulls configuration signals from tools like GitHub and Microsoft products to assess compliance controls in context, extending its SmartPrep capability.
Queensland government entities and Fortescue have settled a dispute over public funding for the Gladstone electrolyser plant, with the state's $66 million outlay preserved for taxpayers through transferred land and infrastructure.
Under RenewEconomy ·leads this story in the feed
A Wollongong hydrogen spin-out is shortlisted for a national award recognising research commercialisation; the profile recaps its electrolyser technology, Port Kembla headquarters, jobs and backing.
Also Dealroom
ENA Respiratory closed a US$22.4 million (A$34 million) Series B backed by Brandon Capital, Uniseed, Stoic Venture Capital, Gates Foundation and Flu Lab, funding Phase II trials of its weekly antiviral nasal spray.
Under Brandon Capital portfolio ·leads this story in the feed
Nano-biotech firm Nexsen has started trading on the ASX after raising $8 million through its IPO, funding its biosensor diagnostics work, with earlier government grant support also detailed.
Under newshub.medianet.com.au ·leads this story in the feed
Deals recorded from Mirage News's coverage. A round is listed once, however many of their articles mention it.
| Company | Stage | Announced | Amount | Investors |
|---|---|---|---|---|
| Q Factorial | Grant | 2 Oct 2026 | $1.1m | |
| iQ Sense | Grant | 2 Oct 2026 | $1.2m | |
| Avicena Systems | Grant | 2 Oct 2026 | $2m | |
| QuantX Labs | Grant | 2 Oct 2026 | $2.2m | |
| FeBI | Grant | 2 Oct 2026 | $2.2m | |
| Silicon Quantum Computing | Grant | 2 Oct 2026 | $3.6m | |
| Hysata | Grant | 18 Sep 2026 | $30m+ | |
| Element Zero | Grant | 2 Sep 2026 | ≤$26m | |
| Australian National University | Grant | 2 Sep 2026 | $1m | |
| Proboxis Biotechnology | Accelerator | 30 Aug 2026 | $1.5m | |
| Ebivanta Therapeutics | Accelerator | 30 Aug 2026 | $1.5m | |
| UXMachines | Grant | 29 Aug 2026 | $190k | |
| ENA Respiratory | Series B | 22 Oct 2025 | $34m | |
| NEXSEN BioTech | Unnamed stage | 14 Oct 2025 | $8m | |
| Fortescue | Grant | undated | $66m |
Companies named in Mirage News's articles, most-covered first.
| Company | What it does | Articles |
|---|---|---|
| FeBI | Medtech startup developing quantum diamond sensor chip to detect blood iron levels | 2 |
| Medical Research Future Fund | 2 | |
| QIMR Berghofer | Medical research institute whose Tumour Immunology Laboratory developed the vaccine candi… | 2 |
| University of Melbourne | University operating the Melbourne Connect innovation precinct | 2 |
| University of Wollongong | University partnering with Green Gravity on technology development | 2 |
| ACCC | Competition regulator that cleared the acquisition subject to divestment conditions | 1 |
| ACWA Power | Saudi power utility | 1 |
| Alcoa of Australia | 1 | |
| Alpine Capital | 1 | |
| Amwins Group | 1 | |
| ARC | 1 | |
| Australian Economic Accelerator | 1 | |
| Australian Financial Review | 1 | |
| Australian National University | University from which Liquid Instruments spun out | 1 |
| Avicena Systems | 1 | |
| Biointelect | 1 | |
| Brandon Capital Partners | 1 | |
| Carbonaught Pty Ltd | 1 | |
| Cook government | 1 | |
| Currus Biologics | Biotech developing the BEAT platform to unlock CAR-T cell therapy for solid tumours | 1 |
| Dijan Training Program | 1 | |
| Dragoneer | 1 | |
| Ebivanta Therapeutics | Developing an mRNA vaccine against Epstein–Barr virus. | 1 |
| Element Zero | Perth green iron company | 1 |
| ENA Respiratory | Antiviral nasal spray to prevent severe respiratory viral infections | 1 |
| EpiMinder | Maker of a continuous seizure monitoring system for epilepsy | 1 |
| eSafety Commissioner | 1 | |
| Florey Institute of Neuroscience and Mental Health | 1 | |
| Fortescue | Mining company using CorePlan's platform | 1 |
| GitHub | 1 | |
| Global Allergy & Airways Patient Platform | patient advocacy group | 1 |
| Hysata | University of Wollongong spin-out developing capillary-fed electrolysis cells for green h… | 1 |
| iQ Sense | 1 | |
| Kia | 1 | |
| KKR | 1 | |
| Magic Valley | cultivated meat producer | 1 |
| Main Sequence Ventures | 1 | |
| MCi Carbon Pty Ltd | 1 | |
| Microsoft | 1 | |
| Neuralink | Brain implant maker that put its first device into a human in 2024 | 1 |
| NEXSEN BioTech | 1 | |
| NSW Government | 1 | |
| Onemda | 1 | |
| Planet Innovation | 1 | |
| POSCO E&C | Engineering and construction subsidiary of POSCO | 1 |
| POSCO Holdings | South Korean steel and energy holding company | 1 |
| Prince of Wales Hospital | 1 | |
| Proboxis Biotechnology | Developing a vaccine production platform for mosquito-borne viruses, beginning with Japan… | 1 |
| Q Factorial | 1 | |
| QuantX Labs | Quantum sensing startup developing optical atomic clock technology | 1 |
| Rewiring Australia | 1 | |
| RMIT University | Melbourne-based university where Michelle Chen completed her PhD and collaborates on rese… | 1 |
| Silicon Quantum Computing | startup founded by Michelle Simmons | 1 |
| Steadfast Group | Australia's largest general insurance broker network | 1 |
| Sunrise Health Service Aboriginal Corporation | 1 | |
| Suzuki | 1 | |
| Synchron | 1 | |
| UniQuest | UQ’s commercialisation company | 1 |
| University of Maryland | 1 | |
| University of Queensland | Research university where Cortisonic's underlying phononic computing research originated | 1 |
| University of Western Australia | University analyzing recovered experimental panels | 1 |
| UQ | 1 | |
| US Food and Drug Administration | 1 | |
| UXMachines | 1 | |
| Volkswagen | 1 |
Investors named in Mirage News's articles, most-covered first.
| Investor | What it does | Articles |
|---|---|---|
| Australian Renewable Energy Agency (ARENA) | 1 | |
| Brandon Capital | 1 | |
| Defence Science Centre | WA government defence science body administering the DaRT grant program | 1 |
| Export Finance Australia | 1 | |
| Flu Lab | 1 | |
| Gates Foundation | 1 | |
| Sojitz Corporation | 1 | |
| State of Queensland | 1 | |
| Stoic Venture Capital | 1 | |
| Australian Renewable Energy Agency | 2 | |
| Biointelect Venturer | A national incubator intended to help turn early-stage infectious disease research into i… | 2 |
| Critical Technologies Challenge Program | 2 | |
| Federal Government | 2 | |
| Uniseed | Venture fund backing early-stage deep tech and life science companies | 2 |
| Australian Government | 7 |